Fortress Biotech (FBIO) Total Non-Current Liabilities (2012 - 2026)

Fortress Biotech's Total Non-Current Liabilities history runs 14 years deep, the most recent figure standing at $121.9 million for Q4 2025.

• In Q4 2025, Total Non-Current Liabilities fell 15.4% year-over-year to $121.9 million; the TTM figure through Dec 2025 stood at $121.9 million (down 15.4% YoY), while the FY2025 annual figure was $121.9 million, down 15.4% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $121.9 million, up from $114.6 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $242.4 million in Q4 2022, with the low at $114.6 million in Q3 2025.
• The 5-year median for Total Non-Current Liabilities is $165.4 million (2023), against an average of $171.8 million.
• The sharpest annual moves came in 2021 and 2023: Total Non-Current Liabilities soared 73.31% in 2021, then sank 32.33% in 2023.
• Fortress Biotech's Total Non-Current Liabilities stood at $168.6 million in 2021, then jumped by 43.8% to $242.4 million in 2022, then tumbled by 32.33% to $164.0 million in 2023, then dropped by 12.15% to $144.1 million in 2024, then decreased by 15.4% to $121.9 million in 2025.
• Business Quant data shows FBIO's Total Non-Current Liabilities at $121.9 million in Q4 2025, $114.6 million in Q3 2025, and $120.8 million in Q2 2025.